Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2025-12-26 @ 11:00 AM
Study NCT ID:
NCT00840606
Status:
COMPLETED
Last Update Posted:
2024-08-19
First Post:
2009-02-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Buspirone Hydrochloride 30mg Tablets, Fasting
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-12
Start Date Type:
None
Primary Completion Date:
2001-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-06
First Submit QC Date:
None
Study First Post Date:
2009-02-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-16
Last Update Post Date:
2024-08-19
Last Update Post Date Type:
ACTUAL